Canada’s vaccine deliveries further threatened as Europe mulls export controls
OTTAWA — Canada’s anxiety-laden COVID-19 vaccine programs are facing further threats as Europe warns drug makers it might impose export controls on European-made vaccine doses.
All of Canada’s current vaccine doses from Pfizer-BioNTech and Moderna are made in Europe, potentially putting at risk the entirety of Canada’s vaccine deliveries.
Europe — like Canada — is being shorted on deliveries from Pfizer as the company slows production to expand its plant in Belgium.
But AstraZeneca has also now informed Europe productions issues will reduce initial deliveries of its vaccine, which Europe is expected to approve for use later this week.